Turn Therapeutics Statistics

Total Valuation

TTRX has a market cap or net worth of $120.64 million. The enterprise value is $115.43 million.

Market Cap	120.64M
Enterprise Value	115.43M

Important Dates

The last earnings date was Monday, May 11, 2026, after market close.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

TTRX has 29.79 million shares outstanding. The number of shares has increased by 4.90% in one year.

Current Share Class	29.79M
Shares Outstanding	29.79M
Shares Change (YoY)	+4.90%
Shares Change (QoQ)	+3.69%
Owned by Insiders (%)	57.78%
Owned by Institutions (%)	1.51%
Float	11.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	19.72
P/TBV Ratio	23.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.98.

Current Ratio	2.23
Quick Ratio	2.19
Debt / Equity	0.98
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -129.17% and return on invested capital (ROIC) is -79.70%.

Return on Equity (ROE)	-129.17%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-79.70%
Return on Capital Employed (ROCE)	-56.94%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.92M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.54
200-Day Moving Average	n/a
Relative Strength Index (RSI)	69.97
Average Volume (20 Days)	19,393

Short Selling Information

The latest short interest is 51,417, so 0.17% of the outstanding shares have been sold short.

Short Interest	51,417
Short Previous Month	60,219
Short % of Shares Out	0.17%
Short % of Float	0.46%
Short Ratio (days to cover)	1.88

Income Statement

Revenue	n/a
Gross Profit	-974,595
Operating Income	-7.69M
Pretax Income	-3.84M
Net Income	-3.84M
EBITDA	-7.64M
EBIT	-7.69M
Earnings Per Share (EPS)	-$0.14

Full Income Statement

Balance Sheet

The company has $11.22 million in cash and $6.01 million in debt, with a net cash position of $5.21 million or $0.17 per share.

Cash & Cash Equivalents	11.22M
Total Debt	6.01M
Net Cash	5.21M
Net Cash Per Share	$0.17
Equity (Book Value)	6.12M
Book Value Per Share	0.21
Working Capital	6.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.90M
Capital Expenditures	n/a
Depreciation & Amortization	54,775
Net Borrowing	6.72M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TTRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.90%
Shareholder Yield	-4.90%
Earnings Yield	-3.18%
FCF Yield	n/a

Analyst Forecast

The average price target for TTRX is $8.00, which is 97.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	97.53%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a